Rob Pieters
Rob Pieters
Hoogleraar University Utrecht
No verified email - Homepage
Title
Cited by
Cited by
Year
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong, JE Staunton, LB Silverman, R Pieters, ML den Boer, ...
Nature genetics 30 (1), 41, 2002
21672002
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
ML Den Boer, M van Slegtenhorst, RX De Menezes, MH Cheok, ...
The lancet oncology 10 (2), 125-134, 2009
8552009
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
J O'Neil, J Grim, P Strack, S Rao, D Tibbitts, C Winter, J Hardwick, ...
Journal of Experimental Medicine 204 (8), 1813-1824, 2007
6722007
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
A Holleman, MH Cheok, ML den Boer, W Yang, AJP Veerman, ...
New England Journal of Medicine 351 (6), 533-542, 2004
6562004
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
R Pieters, M Schrappe, P De Lorenzo, I Hann, G De Rossi, M Felice, ...
The Lancet 370 (9583), 240-250, 2007
6092007
Childhood acute lymphoblastic leukemia: progress through collaboration
CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ...
Journal of Clinical Oncology 33 (27), 2938, 2015
5632015
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
G Wei, D Twomey, J Lamb, K Schlis, J Agarwal, RW Stam, JT Opferman, ...
Cancer cell 10 (4), 331-342, 2006
4992006
Biological and therapeutic aspects of infant leukemia
A Biondi, G Cimino, R Pieters, CH Pui
Blood 96 (1), 24-33, 2000
4942000
L‐asparaginase treatment in acute lymphoblastic leukemia
R Pieters, SP Hunger, J Boos, C Rizzari, L Silverman, A Baruchel, ...
Cancer 117 (2), 238-249, 2011
4732011
Inhibition of FLT3 in MLL: validation of a therapeutic target identified by gene expression based classification
SA Armstrong, AL Kung, ME Mabon, LB Silverman, RW Stam, ...
Cancer cell 3 (2), 173-183, 2003
4692003
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, OG Ottmann, ...
Leukemia 24 (3), 521, 2010
3882010
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
PP Zenatti, D Ribeiro, W Li, L Zuurbier, MC Silva, M Paganin, J Tritapoe, ...
Nature genetics 43 (10), 932, 2011
3732011
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
BV Balgobind, SC Raimondi, J Harbott, M Zimmermann, TA Alonzo, ...
Blood, 2009
3732009
Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia
I Homminga, R Pieters, AW Langerak, JJ de Rooi, A Stubbs, M Verstegen, ...
Cancer cell 19 (4), 484-497, 2011
3182011
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia
GJL Kaspers, AJP Veerman, R Pieters, CH Van Zantwijk, LA Smets, ...
Blood 90 (7), 2723-2729, 1997
3101997
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties
C le Viseur, M Hotfilder, S Bomken, K Wilson, S Röttgers, A Schrauder, ...
Cancer cell 14 (1), 47-58, 2008
3002008
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands
JM De Bont, B Van Der Holt, AW Dekker, P Sonneveld, R Pieters
Leukemia 18 (12), 2032, 2004
2912004
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions
R Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, ...
Blood 76 (11), 2327-2336, 1990
2891990
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants
R Pieters, ML Den Boer, M Durian, G Janka, K Schmiegelow, ...
Leukemia 12 (9), 1344, 1998
2871998
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label …
A Biondi, M Schrappe, P De Lorenzo, A Castor, G Lucchini, V Gandemer, ...
The lancet oncology 13 (9), 936-945, 2012
2802012
The system can't perform the operation now. Try again later.
Articles 1–20